BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 787564)

  • 1. Intrathecal amikacin administration. Use in the treatment of gentamicin-resistant Klebsiella pneumoniae meningitis.
    Hamory B; Ignatiadis P; Sande MA
    JAMA; 1976 Oct; 236(17):1973-4. PubMed ID: 787564
    [No Abstract]   [Full Text] [Related]  

  • 2. Klebsiella meningitis treated with intrathecal amikacin.
    Block CS; Cassel R; Koornhof HJ; Robinson RG; Lewer-Allen CM
    Lancet; 1977 Jun; 1(8026):1371-2. PubMed ID: 69095
    [No Abstract]   [Full Text] [Related]  

  • 3. Emergence of multiple antibiotic resistance during the therapy of Klebsiella pneumoniae meningitis.
    Barriere SL; Conte JE
    Am J Med Sci; 1980; 279(1):61-5. PubMed ID: 6989241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intraventricular amikacin in the treatment of meningoventriculitis caused by Gram-negative organisms].
    Ludeña Carpio C; Madero López L; Barrio Corrales F; Lozano Jiménez C; Martínez Beltrán J; Loza E
    An Esp Pediatr; 1981 Nov; 15(5):503-6. PubMed ID: 7036809
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience with amikacin and colistin in an outbreak of infection by resistant Klebsiella aerogenes.
    Speller DC; Bint AJ; Stephens M
    J Antimicrob Chemother; 1977 Sep; 3(5):483-91. PubMed ID: 332682
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraventricular administration of amikacin for complicated Gram-negative meningitis and ventriculitis.
    Wirt TC; McGee ZA; Oldfield EH; Meacham WF
    J Neurosurg; 1979 Jan; 50(1):95-9. PubMed ID: 363982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intrathecal administration of amikacin in postoperative refractory meningitis].
    Yamashima T; Shoin K; Someya S; Kogure Y; Kubota T; Yamamoto S
    Jpn J Antibiot; 1983 Mar; 36(3):522-8. PubMed ID: 6688276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.
    Smith CE; Tillman BS; Howell AW; Longfield RN; Jorgensen JH
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1290-3. PubMed ID: 2203306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR; Greenman RL; Hoffman TA
    Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
    Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
    Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity of amikacin and gentamicin.
    Shah RM; Heetderks G; Stille W
    Chemotherapy; 1977; 23(4):260-6. PubMed ID: 405182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of intrathecal amikacin in the treatment of postoperative meningitis (author's transl)].
    Takagi K; Fukushima T
    Jpn J Antibiot; 1980 Jun; 33(6):664-7. PubMed ID: 6893845
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple antibiotic resistance and capsular types of gentamicin-resistant Klebsiella aerogenes.
    Casewell MW; Talsania HG
    J Antimicrob Chemother; 1981 Mar; 7(3):237-44. PubMed ID: 7024241
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of Klebsiella pneumonia with complication of CO2-narcosis successfully treated with amikacin (author's transl)].
    Nakagami K; Yatani Y; Osakabe Y; Kunieda T; Suzuki H; Satomi T; Saruta E; Noguchi E
    Jpn J Antibiot; 1980 May; 33(5):641-4. PubMed ID: 7001088
    [No Abstract]   [Full Text] [Related]  

  • 15. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
    Rubens CE; McGee ZA; Farrar WE
    J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Klebsiella neonatal injections: mechanism of broadening aminoglycoside resistance.
    Hardy DJ; Legeai RJ; O'Callaghan RJ
    Antimicrob Agents Chemother; 1980 Oct; 18(4):542-8. PubMed ID: 7004341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of ventriculitis caused by
    Gofman N; To K; Whitman M; Garcia-Morales E
    Am J Health Syst Pharm; 2018 Jul; 75(13):953-957. PubMed ID: 29941534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R-factor mediated gentamicin resistance in "Klebsiella aerogenes". A new problem in nosocomial infection.
    Casewell MW
    Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():419-33. PubMed ID: 400250
    [No Abstract]   [Full Text] [Related]  

  • 19. Relapse of gram-negative bacillary meningitis after cefotaxime therapy.
    Bradsher RW
    JAMA; 1982 Sep; 248(10):1214-5. PubMed ID: 6287048
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined intrathecal and intramuscular gentamicin for gram-negative meningitis. Pharmacologic study of 21 patients.
    Rahal JJ; Hyams PJ; Simberkoff MS; Rubinstein E
    N Engl J Med; 1974 Jun; 290(25):1394-8. PubMed ID: 4208369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.